Sildenafil in severe peripheral ischemia induced by terlipressin. A case report

被引:11
作者
Banuelos Ramirez, David D. [1 ]
Sanchez Alonso, Silvia [1 ]
Ramirez Palma, Maria Magdalena [2 ]
机构
[1] Inst Mexicano Seguro Social, Hosp Especialidades, Ctr Med Nacl, Unidad Med Alta Especialidad, Puebla, Mexico
[2] Inst Mexicano Seguro Social, Adscrita Unidad Medico Familiar 01, Puebla, Mexico
来源
REUMATOLOGIA CLINICA | 2011年 / 7卷 / 01期
关键词
Terlipressine; Ischemia reversal; Sildenafil;
D O I
10.1016/j.reuma.2010.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A female patient in the sixth decade of life developed renal failure secondary to gastrointestinal bleeding, which was non-responsive to conventional therapy. She was treated with terlipressin iv; showing improvement but developing, over the next few days, ischemia and necrosis of the toes in the lower extremities, simulating necrotizing vasculitis, without response to regular management. An alternative therapy, oral sildenafil 50mg BID, was used, with a rapid reversal of the clinical picture. The vasodilator action of sildenafil is useful in cases of ischemia induced by some drugs. The objective this report is to warm about the utility of sildenafil in some potentially severe cases, like the one above. (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:59 / 60
页数:2
相关论文
共 8 条
[1]   The Successful Use of Phosphodiesterase Type 5 Inhibitors to Treat the Syndrome of Cor Pulmonale and Prerenal Azotemia with Diuresis of Anasarca (CorPRADA) [J].
Berez, Paul Bruce .
SOUTHERN MEDICAL JOURNAL, 2010, 103 (02) :116-120
[2]   Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy [J].
Fries, R ;
Shariat, K ;
von Wilmowsky, H ;
Böhm, M .
CIRCULATION, 2005, 112 (19) :2980-2985
[3]   Severe digital ischaemia treated with phosphodiesterase inhibitors [J].
Kumana, CR ;
Cheung, GTY ;
Lau, CS .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) :1522-1524
[4]   Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness [J].
Luks, Andrew M. ;
Swenson, Erik R. .
CHEST, 2008, 133 (03) :744-755
[5]   Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:: A retrospective multicenter study [J].
Moreau, R ;
Durand, F ;
Poynard, T ;
Duhamel, C ;
Cervoni, JP ;
Ichaï, P ;
Abergel, A ;
Halimi, C ;
Pauwels, M ;
Bronowicki, JP ;
Giostra, E ;
Fleurot, C ;
Gurnot, D ;
Nouel, O ;
Renard, P ;
Rivoal, M ;
Blanc, P ;
Coumaros, D ;
Ducloux, S ;
Levy, S ;
Pariente, A ;
Perarnau, JM ;
Roche, J ;
Scribe-Outtas, M ;
Valla, D ;
Bernard, B ;
Samuel, D ;
Butel, J ;
Hadengue, A ;
Platek, A ;
Lebrec, D ;
Cadranel, JF .
GASTROENTEROLOGY, 2002, 122 (04) :923-930
[6]   Terlipressin-induced vasoconstriction reversed with N-acetylcysteine:: A case for combined use in hepatorenal syndrome? [J].
Sen, S ;
Mookerjee, RP ;
Jalan, R .
GASTROENTEROLOGY, 2002, 123 (06) :2160-2161
[7]  
Sharma Rashmi, 2007, Indian J Med Sci, V61, P667
[8]   2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME) [J].
Shindel, Alan W. .
JOURNAL OF SEXUAL MEDICINE, 2009, 6 (07) :1794-1808